Human Endogenous Retroviruses As Epigenetic Therapeutic Targets in TP53-Mutated Diffuse Large B-Cell Lymphoma

In TP53 mutation patients, multiple viral regulation pathways were repressed, resulting in the inhibition of immune modulation, as revealed by gene set enrichment analysis.